Andrea Silber

1.4k total citations
40 papers, 791 citations indexed

About

Andrea Silber is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Andrea Silber has authored 40 papers receiving a total of 791 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 20 papers in Cancer Research and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Andrea Silber's work include Breast Cancer Treatment Studies (13 papers), Advanced Breast Cancer Therapies (10 papers) and Cancer Treatment and Pharmacology (7 papers). Andrea Silber is often cited by papers focused on Breast Cancer Treatment Studies (13 papers), Advanced Breast Cancer Therapies (10 papers) and Cancer Treatment and Pharmacology (7 papers). Andrea Silber collaborates with scholars based in United States, Poland and South Africa. Andrea Silber's co-authors include Lajos Pusztai, Borbála Székely, Christos Hatzis, Veerle Bossuyt, Brigid K. Killelea, David L. Rimm, Malini Harigopal, Ming Zhang, Qin Yan and Giampaolo Bianchini and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Andrea Silber

37 papers receiving 781 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrea Silber United States	15	462	278	172	140	131	40	791
César Sánchez Chile	14	425 0.9×	208 0.7×	180 1.0×	267 1.9×	45 0.3×	81	779
Tira J. Tan Singapore	15	399 0.9×	188 0.7×	139 0.8×	245 1.8×	101 0.8×	56	752
Yunan Han United States	16	337 0.7×	137 0.5×	216 1.3×	152 1.1×	45 0.3×	39	705
Matthew D. Burstein United States	7	640 1.4×	492 1.8×	303 1.8×	363 2.6×	117 0.9×	12	1.1k
Eun Ji Jung South Korea	14	312 0.7×	141 0.5×	159 0.9×	378 2.7×	70 0.5×	24	781
Azita Tiznobaik Iran	7	294 0.6×	184 0.7×	55 0.3×	238 1.7×	70 0.5×	17	838
Nikolaos Charalampakis Greece	12	511 1.1×	163 0.6×	305 1.8×	270 1.9×	163 1.2×	42	988
Tomás Reinert Brazil	15	538 1.2×	366 1.3×	414 2.4×	275 2.0×	42 0.3×	39	1.0k
Eucario León-Rodrı́guez Mexico	13	284 0.6×	85 0.3×	108 0.6×	132 0.9×	95 0.7×	47	641
Amal Ibrahim Egypt	6	256 0.6×	146 0.5×	78 0.5×	196 1.4×	54 0.4×	11	736

Countries citing papers authored by Andrea Silber

Since Specialization

Citations

This map shows the geographic impact of Andrea Silber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Silber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Silber more than expected).

Fields of papers citing papers by Andrea Silber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Silber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Silber. The network helps show where Andrea Silber may publish in the future.

Co-authorship network of co-authors of Andrea Silber

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Silber. A scholar is included among the top collaborators of Andrea Silber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Silber. Andrea Silber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Long, Jessica B., Madhav KC, Terry Hyslop, et al.. (2025). Cardiovascular risk in long-term survivors of breast, prostate, colon, and rectal cancer. JNCI Journal of the National Cancer Institute. 118(1). 130–140.

Long, Jessica B., Terry Hyslop, Andrea Silber, et al.. (2025). Risk of Late-Onset Depression in Long-Term Survivors of Breast, Prostate, and Colorectal Cancer. JAMA Network Open. 8(11). e2544812–e2544812.

Foldi, Julia, Kim Blenman, Michał Marczyk, et al.. (2024). Peripheral blood immune parameters, response, and adverse events after neoadjuvant chemotherapy plus durvalumab in early-stage triple-negative breast cancer. Breast Cancer Research and Treatment. 208(2). 369–377. 1 indexed citations

Marczyk, Michał, et al.. (2024). Trends in breast cancer–specific death by clinical stage at diagnoses between 2000 and 2017. JNCI Journal of the National Cancer Institute. 117(2). 287–295. 3 indexed citations

KC, Madhav, et al.. (2024). Living Flat: Stories from Women of Color After Mastectomy. Annals of Surgical Oncology. 32(1). 104–114. 1 indexed citations

Sanft, Tara, Maura Harrigan, Courtney McGowan, et al.. (2023). Randomized Trial of Exercise and Nutrition on Chemotherapy Completion and Pathologic Complete Response in Women With Breast Cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis Study. Journal of Clinical Oncology. 41(34). 5285–5295. 46 indexed citations

Marczyk, Michał, Andrea Silber, Mariya Rozenblit, et al.. (2023). Trends in breast cancer death by stage at diagnoses in 2000-2018.. Journal of Clinical Oncology. 41(16_suppl). e18855–e18855. 1 indexed citations

Foldi, Julia, Andrea Silber, Tao Qing, et al.. (2022). Clinical Outcomes and Immune Markers by Race in a Phase I/II Clinical Trial of Durvalumab Concomitant with Neoadjuvant Chemotherapy in Early-Stage TNBC. Clinical Cancer Research. 28(17). 3720–3728. 13 indexed citations

Yardley, Denise A., Robyn R. Young, Kerin B. Adelson, et al.. (2021). A Phase II Study Evaluating Orteronel, an Inhibitor of Androgen Biosynthesis, in Patients With Androgen Receptor (AR)-Expressing Metastatic Breast Cancer (MBC). Clinical Breast Cancer. 22(3). 269–278. 9 indexed citations

10.

Sanft, Tara, Maura Harrigan, Brenda Cartmel, et al.. (2021). Effect of healthy diet and exercise on chemotherapy completion rate in women with breast cancer: The Lifestyle, Exercise and Nutrition Early after Diagnosis (LEANer) study: Study protocol for a randomized clinical trial. Contemporary Clinical Trials. 109. 106508–106508. 12 indexed citations

11.

Yardley, Denise A., Robyn R. Young, Kerin B. Adelson, et al.. (2021). Abstract PS11-29: A phase 2 study evaluating orteronel, an inhibitor of androgen biosynthesis, in patients with androgen receptor (AR)-expressing metastatic triple-negative breast cancer (TNBC). Cancer Research. 81(4_Supplement). PS11–29. 1 indexed citations

12.

O’Meara, Tess A., Anton Safonov, David Casadevall, et al.. (2019). Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women. Breast Cancer Research and Treatment. 175(1). 247–259. 42 indexed citations

13.

Foldi, Julia, Sarah S. Mougalian, Andrea Silber, et al.. (2018). Single-arm, neoadjuvant, phase II trial of pertuzumab and trastuzumab administered concomitantly with weekly paclitaxel followed by 5-fluoruracil, epirubicin, and cyclophosphamide (FEC) for stage I–III HER2-positive breast cancer. Breast Cancer Research and Treatment. 169(2). 333–340. 14 indexed citations

14.

Székely, Borbála, Veerle Bossuyt, Xiaofeng Li, et al.. (2018). Immunological differences between primary and metastatic breast cancer. Annals of Oncology. 29(11). 2232–2239. 240 indexed citations

15.

Székely, Borbála, Andrea Silber, & Lajos Pusztai. (2017). New Therapeutic Strategies for Triple-Negative Breast Cancer.. PubMed. 31(2). 130–7. 53 indexed citations

16.

Chagpar, Anees B., Nina Horowitz, Tara Sanft, et al.. (2017). Does lymph node status influence adjuvant therapy decision-making in women 70 years of age or older with clinically node negative hormone receptor positive breast cancer?. The American Journal of Surgery. 214(6). 1082–1088. 30 indexed citations

17.

Wang, Shi‐Yi, Jessica B. Long, Brigid K. Killelea, et al.. (2016). Preoperative breast magnetic resonance imaging and contralateral breast cancer occurrence among older women with ductal carcinoma in situ. Breast Cancer Research and Treatment. 158(1). 139–148. 8 indexed citations

18.

Abu‐Khalaf, Maysa, Sarah S. Mougalian, Tara Sanft, et al.. (2015). A phase II trial of neoadjuvant aromatase inhibitor therapy and the mTOR inhibitor everolimus in postmenopausal women with hormone receptor positive/HER2 negative breast cancer and a low/intermediate risk Oncotype Dx Recurrence Score (≤ 25).. Journal of Clinical Oncology. 1 indexed citations

19.

Abu‐Khalaf, Maysa, Christos Hatzis, Andrea Silber, et al.. (2014). Cardiac outcomes in women receiving aromatase inhibitors as adjuvant endocrine therapy for breast cancer.. Journal of Clinical Oncology. 32(15_suppl). e11501–e11501. 1 indexed citations

20.

Haffty, Bruce G., Doo Ho Choi, Sharad Goyal, et al.. (2009). Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups. Annals of Oncology. 20(10). 1653–1659. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact